検索
Repare Therapeutics Inc
RPTXウォッチリストに追加
2.650USD
0.0000.00%
終値 07/02, 13:00（ET）15分遅れの株価
114.24M時価総額
損失額直近12ヶ月PER
詳細情報 Repare Therapeutics Inc 企業名
Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
Repare Therapeutics Incの企業情報
企業コードRPTX
会社名Repare Therapeutics Inc
上場日Jun 19, 2020
最高経営責任者「CEO」Forte (Steve)
従業員数129
証券種類Ordinary Share
決算期末Jun 19
本社所在地7210 Frederick-Banting, Suite 100
都市ST-LAURENT
証券取引所NASDAQ OMX - NASDAQ BASIC
国Canada
郵便番号H4S 2A1
電話番号18574127018
ウェブサイトhttps://www.reparerx.com/
企業コードRPTX
上場日Jun 19, 2020
最高経営責任者「CEO」Forte (Steve)
Repare Therapeutics Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Michael Zinda, Ph.D.
Dr. Michael Zinda, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
48.78K
--
Mr. Steve Forte
Mr. Steve Forte
President, Chief Executive Officer, Chief Financial Officer, Director
President, Chief Executive Officer, Chief Financial Officer, Director
25.28K
--
Ms. Sandra Alves
Ms. Sandra Alves
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
12.82K
-146.62%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
--
-100.00%
Dr. David P. Bonita, M.D.
Dr. David P. Bonita, M.D.
Independent Director
Independent Director
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Independent Director
Independent Director
--
--
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
--
-100.00%
Mr. Thomas Civik
Mr. Thomas Civik
Independent Chairman of the Board
Independent Chairman of the Board
--
-100.00%
Dr. Susan M. Molineaux, Ph.D.
Dr. Susan M. Molineaux, Ph.D.
Independent Director
Independent Director
--
--
Dr. Steven H. Stein, M.D.
Dr. Steven H. Stein, M.D.
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Michael Zinda, Ph.D.
Dr. Michael Zinda, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
48.78K
--
Mr. Steve Forte
Mr. Steve Forte
President, Chief Executive Officer, Chief Financial Officer, Director
President, Chief Executive Officer, Chief Financial Officer, Director
25.28K
--
Ms. Sandra Alves
Ms. Sandra Alves
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
12.82K
-146.62%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
--
-100.00%
Dr. David P. Bonita, M.D.
Dr. David P. Bonita, M.D.
Independent Director
Independent Director
--
--
Dr. Samarth Kulkarni, Ph.D.
Dr. Samarth Kulkarni, Ph.D.
Independent Director
Independent Director
--
--
よくある質問
Repare Therapeutics Incの上位5名の株主は誰ですか？
Repare Therapeutics Incの上位5名の株主は以下のとおりです。Dr. Michael Zinda, Ph.D.
Repare Therapeutics Inc（RPTX）の株式を保有している機関の数はいくつですか？
2025Q4時点で、Repare Therapeutics Incの株式を保有している機関は116社あり、保有株式の総市場価値は約24.72Mで、全体の57.35%を占めています。2025Q3と比較して、機関の持ち株は-9601917.00増加しています。